Mike Moradi

Mr. Moradi is a successful entrepreneur, having founded or been a principal in several nanotechnology and biopharmaceutical startups. He is a Co-Founder & CEO of Sensulin, LLC, a biopharmaceutical company that is developing a glucose-responsive insulin for Type I and Type II Diabetes, which aims to eliminate the 4-8 daily injections required by T1D patients, in lieu of one daily dose taken with breakfast.   Mr. Moradi earned a Bachelor of Science degree in Biochemistry from the University of Oklahoma.